Evotec Tech Stack

Drug-discovery CRO and CDMO with integrated manufacturing and AI-enabled research

Biotechnology Research Hamburg 5,001–10,000 employees Founded 1993 Public Company

Evotec operates as a full-stack drug-discovery and development partner, spanning target discovery through commercial manufacturing via its Pipeline Co-Creation model. The tech stack reveals heavy operational maturity: MES/DeltaV/Maximo for manufacturing orchestration, LIMS for lab data integrity, and PI System for process monitoring — alongside analytical tools (JMP, R, Python, HPLC, UPLC) — signaling a company managing complex GMP workflows at scale. Hiring is accelerating across manufacturing (35 roles) and research (22 roles), with acute focus on compliance readiness and cost reduction in analytical and purification workflows.

Tech Stack 48 technologies

Core StackPython SAP Power BI Smartsheet Workday Linux Elasticsearch JMP R HPLC UPLC MES DeltaV LIMS Microsoft Office Maximo PI System PI Server PI Vision SQL Aveva PI System OneStream Red Hat Enterprise Linux Ubuntu Logstash Bash Perl Excel PowerPoint Excel Power Pivot+18 more

What Evotec Is Building

◆Challenges

Ensuring gmp compliance
Maintaining gmp compliance
Reducing manufacturing costs
Reducing risk of fih
Ensuring gmp readiness
Compliance with uk hse regulations
Reducing cost of analytical testing
Improving efficiency of analytical testing
Intellectual property challenges for biosimilar formulations
Reducing purification costs

▲Active Projects

Introduction of new products and technologies in the workshop
Audit preparation and execution
Transfer of analytical methods to qc or external laboratories
Development and qualification of analytical methods
Phase-appropriate formulation and stability studies
Training program development
Process validation and comparability study
Technology transfer to manufacturing
New product introduction
New technology implementation

Hiring Activity

Accelerating140 roles · 75 in 30d

Department

Manufacturing

Research

Sales

Engineering

Ops

Marketing

Finance

Product

Seniority

Senior

Mid

Junior

Manager

Director

Lead

Intern

Notable leadership hires: Head of In Silico AI, Inflammation Immunology Head, Head of Innovation, Compliance Director, Business Development Director

Company intelligence

Find more companies like Evotec by tech stack, pain points and active projects

Get started free

About Evotec

Evotec is a publicly traded biotechnology firm headquartered in Hamburg with over 4,000 scientists. The company partners with pharmaceutical companies, biotechs, foundations, and government agencies across drug discovery, development, and manufacturing. Core therapeutic areas include CNS, oncology, inflammation, metabolic disease, and respiratory disease. Revenue model combines research and development services (delivered through fully integrated portfolios or project-based engagements) with CRO and CDMO-like capabilities. Operations span multiple countries: Germany, France, United Kingdom, Italy, and the United States.

HeadquartersHamburg

Company Size5,001–10,000 employees

Founded1993

Hiring MarketsFrance, Germany, United Kingdom, United States, Italy

Frequently Asked Questions

What is Evotec's business model?

Evotec operates as a CRO and CDMO using a Pipeline Co-Creation model — a multi-modality, end-to-end service spanning target discovery, Proof of Concept, and commercial manufacturing. Clients include pharma, biotech, foundations, and government agencies.

What therapeutic areas does Evotec focus on?

Evotec specializes in CNS, oncology, pain, neurosciences, inflammation, metabolic disease, infection, and respiratory diseases. The company employs over 4,000 scientists across these modalities.

Is Evotec hiring manufacturing and quality roles?

Yes. Evotec has 35 active manufacturing roles and is accelerating hiring across operations. Notable openings include compliance and GMP readiness positions, reflecting focus on manufacturing scale and regulatory compliance.